Prostate Cancer Current Events | Prostate Cancer News | 11
|
| Page
11 of
99 |
1971 Results |
|
|
|
Sort By:
Page Views | Date |
Prevent prostate cancer with antioxidants? Gene pathway may reveal more clues
Scientists from Maryland and New Jersey have identified a molecular pathway in mice that makes prostate cells vulnerable to cancer-causing oxygen damage. The pathway, which is also involved in human prostate cancer, may help determine how and whether antioxidants, such as certain vitamins or their products that reverse the damage, can prevent... view more... (2005-09-16)
Mayo Clinic Cancer Center finds better predictors for outcomes after radical prostatectomy
In the largest study of its kind to date, Mayo Clinic researchers report that prostate specific antigen (PSA) kinetics, both velocity and doubling time, can be used to predict disease progression and likelihood of death after radical prostatectomy surgery. view more (2005-11-14)
Increasing Incidence of Prostate Cancer: A Matter of Early Detection?
Over the past five decades, the number of men diagnosed with prostate cancer in Western industrialized nations has been rising - and the cancer is diagnosed at ever younger ages of the patients.This increase is at least partly due to early detection screenings that have been introduced, as is shown by a study of the Deutsches... view more... (2005-01-13)
Radiation therapy prolongs life in men with recurrent prostate cancer
Men whose tumors recur after prostate cancer surgery are three times more likely to survive their disease long term if they undergo radiotherapy within two years of the recurrence. view more (2008-06-18)
Veterans exposed to Agent Orange have higher rates of prostate cancer recurrence
Veterans exposed to Agent Orange have a 48 percent increased risk of prostate cancer recurrence following surgery than their unexposed peers, and when the disease comes back, it seems more aggressive, researchers say. view more (2007-05-21)
Soy found protective against localized prostate cancer
The largest study examining the relationship between the traditional soy-rich Japanese diet and development of prostate cancer in Japanese men has come to a seemingly contradictory conclusion: intake of isoflavone chemicals, derived largely from soy foods, decreased the risk of localized prostate cancer but increased the risk of advanced prostate... view more... (2007-03-16)
Denosumab increases bone density, cuts fracture risk in prostate cancer survivors
Twice-yearly treatment with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer. view more (2009-08-11)
Researchers find first evidence of virus in malignant prostate cells
In a finding with potentially major implications for identifying a viral cause of prostate cancer, researchers at the University of Utah and Columbia University medical schools have reported that a type of virus known to cause leukemia and sarcomas in animals has been found for the first time in malignant human prostate cancer cells. view more (2009-09-08)
New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer
Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases. view more (2009-11-06)
Long-term study shows low oxygen levels in prostate tumors can predict recurrence
Fox Chase Cancer Center researchers have discovered that low-oxygen regions in prostate tumors can be used to predict a rise in prostate-specific antigen (PSA) levels, a marker of tumor recurrence in prostate cancer. view more (2009-05-18)
Study identifies multiple genetic risk factors for prostate cancer
A study led by researchers at the Keck School of Medicine of the University of Southern California (USC) and Harvard Medical School has identified seven genetic risk factors—DNA sequences carried by some people but not others—that predict risk for prostate cancer. view more (2007-04-02)
Study of neighborhoods points to modifiable factors, not race, in cancer disparities
While cities have shown considerable racial disparities in cancer survival, those racial disparities virtually disappear among smaller populations, such as neighborhoods within that city. view more (2009-04-13)
Reactions to 'false-positive' prostate cancer screenings assessed
Men who get a "false-positive" prostate cancer result — an abnormal screening test followed by a biopsy indicating no evidence of cancer — appear more likely to worry about their subsequent risk of cancer and report more problems with sexual function compared to men with normal screening results, according to a University of... view more... (2007-03-05)
Exposure to Agent Orange linked to prostate cancer in Vietnam veterans
UC Davis Cancer Center physicians today released results of research showing that Vietnam War veterans exposed to Agent Orange have greatly increased risks of prostate cancer and even greater risks of getting the most aggressive form of the disease as compared to those who were not exposed. view more (2008-08-05)
Castrate resistant prostate cancer: New therapeutic approaches
Today Dr. Martin Gleave of the Vancouver Prostate Centre in Canada gave a lecture about new approaches to treat castrate-resistant prostate cancer (CRCP) during the 24th Annual Congress of the European Association of Urology in Stockholm, Sweden. view more (2009-03-23)
Vitamin D compounds show promise for prevention of prostate cancer
The active metabolite of vitamin D, calcitriol, and other vitamin D analogs are promising chemopreventive agents that may prevent prostate cancer. view more (2005-11-02)
'Casodex' (bicalutamide) 150mg a cost effective treatment for the management of locally advanced prostate cancer[1]
18th January 2005: New health economic data published in the European Journal of Hospital Pharmacy outline the cost benefits of the non-steroidal anti-androgen bicalutamide 150mg for the treatment of locally advanced prostate cancer. By delaying disease progression in patients with locally advanced prostate cancer, bicalutamide 150mg reduces the... view more... (2005-01-18)
Biomarker predicts malignancy potential of HG-PIN lesions in the prostate
Men whose prostate cancer screenings show high grade prostatic intraepithelial neoplasia (HG-PIN) may find themselves in limbo, "stuck" between diagnoses - they are told prostate cancer has not yet developed, but it might, and they are advised to undergo repeated needle biopsies as a precaution. view more (2008-05-01)
New molecules discovered that block cancer cells from modifying cell DNA
Researchers have discovered new small molecules that may prevent prostate cancer cells from turning off normal genes in a process that transforms normal cells into cancer cells. view more (2007-10-12)
Treatment for early prostate cancer associated with type of specialist seen
A new study analyzing men with localized prostate cancer shows that the specialty of the physician they see can influence the type of therapy they ultimately receive. view more (2007-06-04)
|
|
| Page
11 of
99 |
1971 Results |
|
|
|
Sort By:
Page Views | Date |
|
